Cargando…
First Dose of BNT162b2 mRNA Vaccine in a Healthcare Worker Cohort Is Associated With Reduced Symptomatic and Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
Over the first 2 months of 2021, vaccination coverage of staff at Hull Teaching Hospitals with BNT162b2 increased from 8.3% to 82.5% and was associated with a significant reduction in symptomatic and asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cases. The proportion of p...
Autores principales: | Lillie, Patrick J, O’Brien, Paul, Lawtie, Michelle, Jessop, Steve, Easom, Nicholas J W, Patmore, Russell |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135606/ https://www.ncbi.nlm.nih.gov/pubmed/33893480 http://dx.doi.org/10.1093/cid/ciab351 |
Ejemplares similares
-
Early Serological Response to BNT162b2 mRNA Vaccine in Healthcare Workers
por: Cocomazzi, Giovanna, et al.
Publicado: (2021) -
Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infection
por: Puranik, Arjun, et al.
Publicado: (2022) -
Effectiveness of the BNT162b2 mRNA Covid-19 vaccine in Spanish healthcare workers
por: Núñez López, Concepción, et al.
Publicado: (2023) -
Effectiveness of the BNT162b2 mRNA Covid-19 vaccine in Spanish healthcare workers
por: Núñez López, Concepción, et al.
Publicado: (2023) -
Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination
por: Nishiguchi, Yamato, et al.
Publicado: (2021)